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Probe-based confocal laser endomicroscopy in COVID-19
Abstract
Probe-based confocal laser endomicroscopy (pCLE) is a method that produces microscopic imaging of a lung tissue during 
bronchoscopy. We report a case ot a patient with negative nasopharyngeal swabs and suspected lung cancer who underwent 
pCLE. The diagnosis of COVID-19 was confirmed by PCR analyses of lavage fluid and transbrohial biopsy. The pCLE image shows 
density of alveolar thickened fibres, disorganization of elastin network, and multiple large drops of intraalveolar secretions. As far 
as we know, this is the first pCLE image discribed in patient with COVID-19 at that moment.
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Introduction
Coronavirus disease 2019 (COVID-19) is 
a type of lower respiratory tract infection with 
the potential to cause severe and possibly fa-
tal atypical pneumonia in humans caused by 
Severe Acute Respiratory Syndrome Corona-
virus 2 (SARS-CoV-2), initially named novel 
coronavirus or 2019-nCoV [1]. The first cases 
of COVID-19 were reported in Wuhan, Chi-
na in early December 2019 [2]. Since then, 
COVID-19 has become a global pandemic due 
to its transmissibility resulting in it spreading 
across continents with the number of cases and 
deaths rising daily [3]. 
Probe-based confocal laser endomicroscopy 
(pCLE) is a technique that produces microscopic 
imaging of living tissue through a fiberoptic 
miniprobe that can be introduced into the 
working channel of the bronchoscope [4]. This 
method could be used in the diagnosis of lung 
cancer and interstitial lung diseases [5, 6]. We 
did not find any scientific articles about pCLE 
images of COVID-19. We introduce a case where 
pCLE was used in a patient with suspected 
lung cancer who had subsequently confirmed 
COVID-19.
Case Report
An 87-year-old male who was a non-smoker 
was admitted to our clinic with complaints of 
weakness, shortness of breath on exertion, and 
cough. From May 12, 2020, the patient developed 
cough and fever up to 38.0°C after experiencing 
hypothermia. Nasopharyngeal swabs for RT-PCR 
SARS-CoV-2 were negative. CT scans revealed 
obstruction of the segmental bronchi of the upper 
lobe of the left lung with development of obstruc-
tive pneumonitis and pleurisy (Figure 1). The 
patient underwent a pleural puncture and 160 mL 
of cloudy, bright yellow liquid with reddish loose 
sediment was evacuated.
The effusion had no signs of malignancy and 
contained blood elements, lymphocytes, histio-
cytes, and mesothelial cells.
The patient was hospitalized in the clinic in 
order to diagnose his pneumonia as being post-ob-
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structive or bacterial/viral in origin. Lung cancer 
was also suspected.
His comorbidities include coronary artery 
disease, aortic valve replacement for severe aortic 
stenosis (2013), superficial thrombophlebitis of 
the saphenous veins of both legs, type 2 diabe-
tes mellitus with diabetic polyneuropathy and 
diabetic nephropathy, autoimmune thyroiditis, 
cholecystectomy (1986), and chronic prostatitis.
After the first day of hospitalization, the pa-
tient experienced a sharp deterioration in breath-
ing and a decrease in blood oxygen saturation 
(89%) which required artificial ventilation. 
Because of the negative smears for RT-PCR 
SARS-CoV-2 and suspected lung cancer, it was 
decided to perform bronchoscopy with transbron-
chial biopsy and confocal laser endomicroscopy. 
Bronchoscopy was performed in the inten-
sive care unit by a limited number of staff who 
donned personal protective equipment (PPE). 
During bronchoscopy, a moderate amount of 
liquid-mucous hemorrhagic secretion was noted 
on both sides, and the bronchus of left segment 
3 was obturated with a blood clot. The lumens 
of the other bronchi were ordinary. pCLE was 
performed using the Cellvizio system and 1.4-
mm probe Alveoflex (Mauna Kea Technologies, 
Paris, France). After removal of the clot, no en-
dobronchial lesions were found. The miniprobe 
was introduced into all subsegments of the left 
upper lobe. The pCLE image showed changes in 
the alveolar frame with increased density up to 
the point where alveolar structures were absent, 
thickening of elastic fibers, and a large amount 
of intra-alveolar secretions (Figure 2). Transbron-
chial lung biopsy (TBB) was performed from the 
zones of moderate and severe disorganization of 
lung tissue by pCLE image data. Also, bronchoal-
veolar lavage from left upper segmental bronchi 
for RT-PCR SARS-CoV-2 was performed.
Histological examination revealed signs of 
diffuse alveolar damage with fibrin, pneumocytes, 
and macrophages present without any atypical 
cells (Figure 3). PCR analysis of bronchoalveolar 
lavage fluid yielded a positive result for SARS-
CoV-2. Appropriate treatment was started. Un-
fortunately, the pneumonia evolved and became 
bilateral. It eventually progressed to respiratory 
failure and subsequently caused the death of the 
patient. Postmortem examination did not reveal 
any signs of malignancy, and the pneumonia was 
confirmed.
Discussion
The diagnosis of COVID-19 is based on spe-
cific symptoms, history of contact with an in-
fected person, and bilateral lung involvement 
on CT-scans. The diagnosis is confirmed by 
a positive nucleic acid test for SARS-CoV-2 com-
monly from oropharyngeal and nasopharyngeal 
swabs or bronchoalveolar lavage fluid (BALF) 
[7]. A nasopharyngeal or oropharyngeal swab 
for the SARS-CoV-2 RT-PCR test is the primary 
and preferred method for diagnosis of COVID-19, 
but its sensitivity varies from 53.6% to 73.3% 
and from 11.1% to 61.3%, respectively. Their 
accuracy also depends on how many days have 
passed since illness onset [8]. Positive rates from 
BALF in infected patients have been noted in up 
to 100% of patients, but all guidelines suggest 
that bronchoscopy is relatively contraindicated 
in COVID-19 and/or should play a limited role 
in diagnosis and management because of the 
high risk of spreading the infection to the staff 
involved in the procedure [9]. However, the use 
of bronchoscopy may be justified if an alternative 
diagnosis which would change management is 
suspected [7, 9].
In our case, the diagnosis of COVID-19 was 
not clear because of the initially unilateral lung 
infiltrate and pleurisy on CT-scans, and negative 
nasopharyngeal swab tests. The patient was hos-
pitalized with suspected lung cancer. Probe-based 
confocal laser endomicroscopy showed density 
of alveolar thickened fibres, thickening of elastin 
fibres, and multiple large drops of intraalveolar 
secretions. In pCLE images, no solid pattern 
consistent with a malignant disease was noted 
which allowed us to exclude lung cancer in the 
differential diagnosis [5]. Histological examina-
Figure 1. CT-scans showed a large area of consolidation in the left 
upper lobe (*) and moderate pleural effusion (**)
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Figure 2. pCLE images of lung tissue of the left upper lobe. Intraalveolar fiber thickness (yellow line), increased density of elastic structures (white 
arrow) up to disappearance of alveolar structures (yellow arrow), and large drops of intraalveolar secretions (*)
Figure 3. Pathological examination of TBB samples. A. Diffuse alveolar damage, proliferative phase: there is a small amount of pneumocytes in the 
alveoli (black arrow), macrophages (blue arrow), and fibrin (*); × 100, stained with hematoxylin and eosin. B. Diffuse alveolar damage, proliferative 
phase: accumulation of fibrin in the lumen of the alveoli with polypoid growths of connective tissue (brown arrow), interstitial inflammation with 
thickening and edema of interalveolar septa (black arrow), and microangiopathy and thrombosis of the vascular bed (blue arrow), stained with 
hematoxylin and eosin, × 40
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tion of TBB specimens revealed signs of diffuse 
alveolar damage described in COVID-19 [10]. To 
the best of our knowledge, this is the first pCLE 
image of a patient with COVID-19. This image 
was not significantly different from other images 
seen in interstitial lung diseases [6].
Conclusion 
pCLE can be a useful method for suspecting 
or excluding a diagnosis of COVID-19 in real 
time if nasopharyngeal swab tests are negative 
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